A multicenter retrospective cohort study to characterize patients hospitalized with MIS-A and COVID-19 in the United States, 2020–2021
✅ Just Accepted
https://t.co/4zl0yXSS8f
Learning about current outcome measures and future directions for assessing dAEs (dermatological adverse events) from Dr. Sheila Shaigany @NorthwellHealth#CHORD2021#dermtwitter
We're thrilled that our research, ‘Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations’ has been published by @jaadjournals! Join us in learning the different ways that HS affects health.